Search Results 8481-8490 of 42325 for oral
... oral anticoagulants. J Interv Card Electrophysiol. 2019 Jan; 54 (1):81-89 Epub 2018 Sept 19. View PubMed; Isath A, Padmanabhan D, Naksuk N, Kella D, Friedman ...
of these products during palovarotene treatment. - Exposure to synthetic oral retinoids other than palovarotene within 4 weeks of the. Inclusion Visit ...
oral TNG908 6. Active prior or concurrent malignancy. 7. Central nervous system metastases associated with progressive neurological symptoms 8. Current ...
mycobacterium avium-intracellulare infection (MAI), fungus, tuberculosis). 2. Patient has a steroid-dependent condition requiring >10 mg of oral corticosteroid ...
Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral medicines that may help stop or delay ...
Current regular use of oral anti-hyperglycemia agents for the treatment of diabetes; Documented diabetes by American Diabetes Association (ADA) and/or World ...
Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating the ...
Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating ...
... oral absorption or tolerance of ixazomib or idasanutlin including difficulty swallowing; Diarrhea > grade 1, based on the National Cancer Institute (NCI) ...
Oral contraception containing progestins only; IUD progesterone T; Female condom; Natural family planning (rhythm method) or breastfeeding; Fertility awareness ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.